08048035996
Transplant TACROGRAF 0.25mg Capsules trusted to Canada - Toronto | Phoenix Exim | Global Exporter

1. General Information

TACROGRAF 0.25 mg is an oral capsule containing Tacrolimus 0.25 mg. Tacrolimus belongs to the calcineurin-inhibitor class of immunosuppressants. Its principal role is to reduce the immune response so that the body's immune system is less likely to attack a transplanted organ.

It is a prescription medicine and should be used only under the supervision of a transplant specialist or other qualified physician experienced in immunosuppressive therapy.

2. Product Information

  • Brand: TACROGRAF
  • Strength: 0.25 mg
  • Active Ingredient: Tacrolimus 0.25 mg
  • Dosage Form: Capsule
  • Therapeutic Class: Immunosuppressant
  • Primary Use: Prevention of organ rejection after transplantation
  • Common Transplant Uses: Kidney, liver, and heart transplantation
  • Route: Oral
  • Manufacturer/Marketer: Eris Lifesciences Ltd. is listed as the marketer for Tacrograf 0.25 Capsule in Indian medicine references.
  • Storage: Store according to the product label; Indian product information lists storage below 25°C.

3. Uses of TACROGRAF 0.25 mg

TACROGRAF is primarily used to help prevent rejection of a transplanted organ. Tacrolimus capsules are indicated for prevention of rejection in adult kidney, liver, and heart transplant recipients, generally in combination with other immunosuppressive medicines.

The medicine may be prescribed as part of a long-term transplant-treatment regimen. The exact regimen depends on the organ transplanted, the patient's clinical condition, other medicines, and blood tacrolimus levels.

4. Benefits of TACROGRAF 0.25 mg

The principal therapeutic benefit is suppression of excessive immune activity following organ transplantation. This helps reduce the likelihood that the immune system will recognize the transplanted organ as foreign and attack it.

Other potential benefits include:

  • Helps maintain acceptance of a transplanted organ.
  • Can be incorporated into individualized post-transplant immunosuppressive treatment.
  • Helps reduce the risk of immune-mediated organ rejection when taken as prescribed.
  • The 0.25 mg strength can be useful when physicians need to make precise dose adjustments.

5. Side Effects of TACROGRAF 0.25 mg

Tacrolimus can cause side effects because it suppresses the immune system and affects several body systems. Important possible adverse effects include kidney problems, increased blood glucose, high blood pressure, tremors, headache, insomnia, infections, and abnormal liver-function tests.

Tacrolimus also carries serious warnings concerning serious infections and malignancies associated with immunosuppression.

Seek medical attention promptly for symptoms such as severe infection, significant reduction in urine, unusual bleeding or bruising, severe neurological symptoms, or other concerning changes.

6. Common Side Effects

Some commonly reported side effects include:

  • Tremors or shakiness
  • Headache
  • Difficulty sleeping
  • Increased blood glucose
  • High blood pressure
  • Nausea or diarrhoea
  • Increased susceptibility to infections
  • Abnormal liver-function tests
  • Changes in kidney function

Not everyone experiences these effects, and their severity can vary. Persistent or worsening symptoms should be discussed with the treating physician.

7. How to Use TACROGRAF 0.25 mg

Take TACROGRAF exactly as prescribed by your transplant specialist. The dose is individualized according to factors such as the type of transplant, body weight, other medicines, clinical response, and tacrolimus blood concentrations.

  • Swallow the capsule as directed.
  • Take it consistently at the same times each day.
  • It may be taken with or without food, but maintain the same relationship to food each time.
  • Do not change the dose yourself.
  • Do not stop treatment without consulting your doctor because interruption can increase the risk of transplant rejection.
  • Regular blood tests are generally required to monitor tacrolimus levels and safety parameters.
  • Avoid grapefruit and grapefruit juice unless your treating physician specifically advises otherwise.

8. How TACROGRAF 0.25 mg Works

Tacrolimus is a calcineurin inhibitor. It suppresses activation of certain immune cells, particularly T-lymphocytes, thereby reducing the immune response against the transplanted organ. This immunosuppressive action helps the body accept the transplanted organ rather than mounting an immune attack against it.

9. Safety Advice

Because TACROGRAF is a potent immunosuppressant, it requires careful medical supervision.

Important precautions:

  • Use only under specialist medical supervision.
  • Regularly monitor tacrolimus blood levels as recommended.
  • Kidney function, liver function, blood pressure, blood glucose, and other laboratory parameters may require monitoring.
  • Tell your doctor about kidney, liver, heart, diabetes, or blood-pressure problems before treatment.
  • Tacrolimus can increase susceptibility to infections; report fever, persistent sore throat, mouth ulcers, or other signs of infection.
  • Avoid grapefruit/grapefruit juice because it can alter tacrolimus exposure.
  • Discuss pregnancy or breastfeeding with your physician before use.
  • Inform your doctor about all prescription medicines, over-the-counter medicines, supplements, and herbal products because tacrolimus has clinically important drug interactions.
  • Do not substitute one tacrolimus product or formulation without medical guidance; maintaining consistent treatment and monitoring is important.
  • Never discontinue tacrolimus abruptly without medical advice.

10. Frequently Asked Questions (FAQs)

Q1. What is TACROGRAF 0.25 mg used for?
TACROGRAF 0.25 mg is used as an immunosuppressant to help prevent rejection of transplanted organs, including kidney, liver, and heart transplants.

Q2. What is the active ingredient in TACROGRAF 0.25 mg?
It contains Tacrolimus 0.25 mg.

Q3. Is TACROGRAF a prescription medicine?
Yes. Tacrolimus requires medical supervision and therapeutic monitoring.

Q4. Can I stop TACROGRAF if I feel better?
No. Do not stop it without your transplant specialist's instruction because stopping immunosuppression can increase the risk of organ rejection.

Q5. Does TACROGRAF affect the kidneys?
Tacrolimus can affect kidney function, so regular monitoring of renal function is important.

Q6. Can TACROGRAF increase blood sugar?
Yes. Increased blood glucose is a recognized adverse effect, and blood glucose may need monitoring during treatment.

Q7. Can TACROGRAF increase the risk of infections?
Yes. Because it suppresses the immune system, patients can become more susceptible to infections.

Q8. Can I take TACROGRAF with food?
Tacrolimus capsules can generally be taken with or without food, but they should be taken consistently in relation to meals.

Q9. Should grapefruit juice be avoided?
Yes. Official prescribing information advises avoiding grapefruit and grapefruit juice because they can affect tacrolimus exposure.

Q10. Is TACROGRAF 0.25 mg suitable for every transplant patient?
No. Tacrolimus dosing is individualized according to the transplant type, patient characteristics, concomitant medicines, and measured blood levels. A transplant specialist should determine the appropriate regimen.

11. Substitute for TACROGRAF 0.25 mg

Medicines containing the **same active ingredient and strength—Tacrolimus 0.25 mg—**may be considered alternatives, but substitution should be approved by the treating transplant physician.

Examples listed in Indian medicine references include:

  • Pangraf 0.25 Capsule
  • Tacromus 0.25 Capsule
  • Tacroren 0.25 mg Capsule
  • Tacstead 0.25 mg Capsule
  • Vingraf 0.25 Capsule

These products should not be switched automatically. Tacrolimus has a narrow therapeutic range, and product/formulation changes may require additional monitoring.

12. Keywords

Primary Keywords:

  • TACROGRAF 0.25 mg Capsules
  • Tacrograf 0.25 mg
  • Tacrolimus 0.25 mg Capsules
  • Tacrolimus Capsules exporter
  • Tacrolimus 0.25 mg supplier
  • Tacrolimus medicine exporter from India
  • TACROGRAF 0.25 mg exporter India
  • Immunosuppressant medicine exporter
  • Organ transplant medicine supplier
  • Organ rejection prevention medicine

Long-Tail SEO Keywords:

  • TACROGRAF 0.25 mg Capsules exporter from Nagpur India
  • Tacrolimus 0.25 mg Capsules pharmaceutical exporter from India
  • Genuine TACROGRAF 0.25 mg Capsules supplier from India
  • Tacrolimus 0.25 mg medicine exporter to USA
  • Tacrolimus 0.25 mg Capsules exporter to UK
  • TACROGRAF 0.25 mg supplier to Australia
  • Tacrolimus 0.25 mg pharmaceutical exporter to Singapore
  • TACROGRAF 0.25 mg exporter to Canada
  • Tacrolimus 0.25 mg medicine supplier to South Korea
  • TACROGRAF 0.25 mg exporter to UAE
  • Tacrolimus Capsules wholesale pharmaceutical supplier India
  • Tacrolimus 0.25 mg international medicine supplier
  • TACROGRAF 0.25 mg post-transplant medicine supplier
  • Tacrolimus 0.25 mg organ transplant medicine exporter
  • Genuine Tacrolimus 0.25 mg Capsules from India
Aug 21st, 2026 3:13 PM

Keywords